The Claim
Approximately 62% of new-onset diabetes cases associated with statin therapy occur in individuals whose baseline glycaemic markers are in the highest quartile, suggesting that individuals closest to the diabetes threshold are most susceptible to developing diabetes due to statin-induced glycaemic changes.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Most people who get diabetes from taking statins were already close to having it — about 6 out of 10 had blood sugar levels near the danger zone before starting the medication.
See the scientific wording
Approximately 62% of new-onset diabetes cases attributed to statin therapy occur in individuals whose baseline glycaemic markers are in the highest quartile, indicating that those closest to the diabetes threshold are most likely to be diagnosed due to statin-induced glycaemic shifts.
What the research says
1 studyThe study found that most people who developed diabetes while on statins were already close to having it before starting the medication, which matches the claim.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.